Buy Exelixis Stock | EXEL Stock Price & Latest News | Public.com

Exelixis

$0.00 (0.00%)Today

About EXEL

Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. ...Read more

Community

People who own or watch this stock

News

News image
Got $3,000? 3 Growth Stocks You Won't Regret Buying
1
0

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.6

Price Targets

What analysts think this stock will be worth

$24.94
current
$29.85
average

Events

List of events that could affect this stock.

05May

Earnings data Q1 2020

29Jul

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0.22
0.15
0.07
0
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

$0.10

Actual EPS
Q3 2020

Stats

Market Cap$7,41B
Volume134,97k
Price-to-Earnings Ratio25.94
Dividend Rate
Dividend Yield
1 Year High$27.80
1 Year Low$13.67
Open$24.28
High$25.40
Low$24.28

Buy any stock with any amount of money.

Download the App
Download the app